Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Merck & Company Inc (MRK)

Healthcare Drug Manufacturers - General
130.20 $
+0.3% vs. previous close
Closing price · As of: 31. Jul 2026

Merck & Company Inc (MRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 128,685 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet MRK
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
104,469 106,727 106,675 105,849 112,630 117,532 117,106 115,122 117,523 129,546 136,866 128,685
29,977 31,954 32,168 31,445 38,205 40,361 38,782 35,503 37,065 47,557 43,516 35,015
5,660 8,605 6,841 5,579 11,304 14,593 13,242 8,629 8,007 18,169 14,565 5,327
6,378 8,773 7,093 11,354 14,593 13,689 9,228 8,622 18,214 14,565 5,702
11,030 10,394 10,349 11,366 11,642 11,381 10,278 10,790 11,846 12,120 12,679 12,210
5,930 6,131 6,358 6,510 6,469 6,244 6,109 6,196 6,601 6,444 6,658 6,479
22,231 22,526 23,446 23,779 24,793 25,236 25,639 25,316
21,195 21,183 21,197 21,181 21,161 21,697 21,668 21,684 21,591 21,587 21,579 21,581
19,665 19,199 18,011 17,572 16,984 17,010 16,370 15,758 15,193 15,313 26,681 25,745
65,727 65,427 69,040 65,425 68,982 72,972 70,734 66,722 68,463 77,639 84,204 82,754
23,394 23,094 25,694 25,099 26,060 29,586 28,420 25,174 26,037 28,628 28,327 26,945
2,839 887 1,657 3,071 3,149 2,931 1,360 1,434 1,405 2,883 2,444
3,442 3,509 3,922 3,514 3,519 3,586 4,079 3,784 3,892 4,147 4,404 3,863
34,072 33,972 33,683 31,142 34,717 34,982 34,462 33,484 33,968 39,969 46,750 46,673
38,693 41,246 37,581 40,364 43,582 44,502 46,313 48,335 48,993 51,850 52,606 45,878
54,198 57,082 53,895 56,697 60,187 61,384 63,069 66,097 68,477 72,231 73,075 66,721
2,539 2,546 2,554 2,533 2,544 2,541 2,541 2,531 2,513 2,498 2,488 2,472

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?